Bone mineral density improvement in spondyloarthropathy after treatment with etanercept

被引：32
作者：
Marzo-Ortega, H
McGonagle, D
Haugeberg, G
Green, MJ
Stewart, SP
Emery, P
机构：
[1] Leeds Gen Infirm, Rheumatol & Rehabil Res Unit, Leeds LS1 3EX, W Yorkshire, England
[2] Calderdale Gen Hosp, Dept Rheumatol, Halifax, NS HX3 0PW, Canada
[3] Diakonhjemmet Hosp, Oslo City Dept Rheumatol, N-0318 Oslo, Norway
[4] Univ Leeds, Acad Unit Med Phys, Leeds LS1 3EX, W Yorkshire, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2003年 / 62卷 / 10期
关键词：
D O I：
10.1136/ard.62.10.1020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1020 / 1021
页数：2
相关论文
共 8 条
  • [1] Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2αA) is inhibited by tumor necrosis factor-α
    Gilbert, L
    He, XF
    Farmer, P
    Rubin, J
    Drissi, H
    van Wijnen, AJ
    Lian, JB
    Stein, GS
    Nanes, MS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (04) : 2695 - 2701
  • [2] Gratacós J, 1999, ARTHRITIS RHEUM, V42, P2319, DOI 10.1002/1529-0131(199911)42:11<2319::AID-ANR9>3.0.CO
  • [3] 2-G
  • [4] Hofbauer LC, 2001, ARTHRITIS RHEUM-US, V44, P253, DOI 10.1002/1529-0131(200102)44:2<253::AID-ANR41>3.0.CO
  • [5] 2-S
  • [6] Marzo-Ortega H, 2001, ARTHRITIS RHEUM-US, V44, P2112, DOI 10.1002/1529-0131(200109)44:9<2112::AID-ART363>3.0.CO
  • [7] 2-H
  • [8] MARZOORTEGA H, 2002, RHEUMATOLOGY OXFOR S, V41, pS311
1